Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
Mice were treated with pharmacological agents by either intraperitoneal (i.p.) injection or inclusion in the drinking water
Models with genetically inactivated TP53 exhibited resistance attributed to compensatory CDK2 activity, a constraint that might be mitigated by APR-246, a small chemical that reactivates mutant TP53
Specifications Content: Dihexa (lyophilised) Form: Freeze-dried powder Purity: 98% (HPLC-verified) COA: Certificate of Analysis provided with each batch Storage: 20C prior to dispatch Intended Use: Laboratory research only This product is intended strictly for laboratory research purposes and is not approved for human consumption, animal use, therapeutic applications, or diagnostic procedures.
Convenient and Hygienic: Packaged in a sleek, easy-to-use container that ensures hygienic application and convenience for nightly use
GhezzoAViscontiPAbruzzoPMBolottaAFerreriCGobbiGet al
Research compound only
